source
- FDA releases draft guidance to speed cell and gene therapy approvalsThe FDA announced a draft guidance aimed at helping developers bring gene therapies to patients more quickly. It encourages use of publicly available scientific data and existing platform knowledge…
- Longevity startup NewLimit secures $435 million Series C as it prepares first liver drug trialNewLimit, a longevity‑focused biotech founded in 2021, announced a Series C financing that brought in $435 million, pushing its valuation to about $3.1 billion. The round was led by Founders Fund…